India · Delayed Price · Currency is INR Valiant Laboratories Statistics
Total Valuation
NSE:VALIANTLAB has a market cap or net worth of INR 4.54 billion. The enterprise value is 4.99 billion.
| Market Cap | 4.54B |
| Enterprise Value | 4.99B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:VALIANTLAB has 54.31 million shares outstanding. The number of shares has increased by 7.22% in one year.
| Current Share Class | 54.31M |
| Shares Outstanding | 54.31M |
| Shares Change (YoY) | +7.22% |
| Shares Change (QoQ) | -1.41% |
| Owned by Insiders (%) | 24.35% |
| Owned by Institutions (%) | 3.47% |
| Float | 20.23M |
Valuation Ratios
The trailing PE ratio is 3,515.58.
| PE Ratio | 3,515.58 |
| Forward PE | n/a |
| PS Ratio | 2.81 |
| PB Ratio | 1.94 |
| P/TBV Ratio | 1.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 3,869.81 |
| EV / Sales | 3.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 641.64 |
| Debt / FCF | n/a |
| Interest Coverage | -10.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -0.37% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 20.42M |
| Profits Per Employee | 16,329 |
| Employee Count | 79 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:VALIANTLAB has paid 9.69 million in taxes.
| Income Tax | 9.69M |
| Effective Tax Rate | 88.25% |
Stock Price Statistics
The stock price has decreased by -28.58% in the last 52 weeks. The beta is -0.31, so NSE:VALIANTLAB's price volatility has been lower than the market average.
| Beta (5Y) | -0.31 |
| 52-Week Price Change | -28.58% |
| 50-Day Moving Average | 85.03 |
| 200-Day Moving Average | 94.52 |
| Relative Strength Index (RSI) | 46.54 |
| Average Volume (20 Days) | 30,518 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:VALIANTLAB had revenue of INR 1.61 billion and earned 1.29 million in profits. Earnings per share was 0.03.
| Revenue | 1.61B |
| Gross Profit | 240.00M |
| Operating Income | -19.82M |
| Pretax Income | 10.98M |
| Net Income | 1.29M |
| EBITDA | 1.90M |
| EBIT | -19.82M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 759.91 million in cash and 1.22 billion in debt, giving a net cash position of -456.96 million or -8.41 per share.
| Cash & Cash Equivalents | 759.91M |
| Total Debt | 1.22B |
| Net Cash | -456.96M |
| Net Cash Per Share | -8.41 |
| Equity (Book Value) | 2.34B |
| Book Value Per Share | 53.28 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 14.88%, with operating and profit margins of -1.23% and 0.08%.
| Gross Margin | 14.88% |
| Operating Margin | -1.23% |
| Pretax Margin | 0.68% |
| Profit Margin | 0.08% |
| EBITDA Margin | 0.12% |
| EBIT Margin | -1.23% |
| FCF Margin | n/a |
Dividends & Yields
NSE:VALIANTLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.22% |
| Shareholder Yield | -7.22% |
| Earnings Yield | 0.03% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |